FDA Approves First Targeted Therapy for HER2-Low Breast Cancer

FDA Approves First Targeted Therapy for HER2-Low Breast Cancer

Source: FDA Center for Drug Evaluation and Research - What's New - August 5, 2022 Category: Drugs & Pharmacology Authors: FDA Source Type: news